News

Colorectal cancer constitutes one of the leading causes of cancer-related deaths worldwide. A German research group has shown that the expression of Interleukin-8, a multifunctional cytokine ...
The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.
Abstract We have recently reported that interleukin-8 (IL-8) expression was inversely correlated to estrogen receptor (ER) status and was overexpressed in invasive breast cancer cells.
Interleukin-8 (IL-8), a chemokine implicated in the metastasis and angiogenesis of a variety of cancers, has been reported to be overexpressed in prostate cancer. In this study, we ascribe a new ...
Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study Authors: Ayalew Tefferi ...
Cancer treatment has long faced a challenging trade-off: therapies strong enough to eliminate tumors often cause severe side effects. One promising solution involves cytokines, natural proteins that ...
In patients with rheumatologic diseases, treatment with interleukin inhibitors may increase the risk of serious infections, opportunistic infections, and cancer, according to a systematic review ...
The trial is spearheaded by Dr Jonathan Hernandez, the surgical oncology section chief of the National Cancer Institute.
Now researchers have identified a “jamming signal” that cancer uses to hide from the immune system, and engineered a synthetic immune cell that can fight back.
In a new study, researchers compared serum cytokine expression among healthy individuals and those with PASC [post-acute sequelae of coronavirus disease 2019 (COVID-19)].
Accordingly, interleukin-17–producing cells are diminished in patients with the hyper-IgE syndrome, providing the first evidence of the critical role this cytokine plays in humans. 18–20 ...